Numares AG, Regensburg, Germany, offers the RenalTx-Score test for the diagnosis of kidney rejection. The test evaluates a multimetabolite biomarker network rather than single biomarkers or tissue biopsy for the diagnosis of an acute rejection reaction following a kidney transplant. Available as part of Numares’ Axinon in vitro diagnostic system, the test creates and evaluates a nuclear magnetic resonance spectrum from a urine sample. If the result indicates that a patient may be experiencing an acute rejection reaction, the patient can be referred for biopsy to confirm the result or for therapeutic intervention. The test seeks to enable a regular and close monitoring of the transplanted kidney without additional strain on the patient or the organ. For more information, visit Numares.